The strategic investment project “Setting up industrial production of biological substances and finished dosage forms and mastering manufacturing of industrial products that do not have Russian-made analogues” is entering the final stage of implementation – installation of equipment began in the building intended for manufacturing.
The project is implemented by BIOCAD as investor and involves the construction of high-tech production of biological substances and finished dosage forms.
Within the framework of the investment project, it is planned to manufacture 13 international non-proprietary names of medicines, 6 of which being the company’s own original developments.
Also within the project, it is planned to create more than 180 new jobs. The total investment in the project is more than 3 billion rubles. The production start is scheduled for 2019.